Vivos (RDGL) Revenue (QoQ) (2011 - 2025)
Vivos (RDGL) Revenue (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,217.30% |
| Sep 30, 2025 | -87.47% |
| Jun 30, 2025 | -43.92% |
| Mar 31, 2025 | 435.50% |
| Dec 31, 2024 | -0.10% |
| Sep 30, 2024 | -62.96% |
| Jun 30, 2024 | 200.00% |
| Sep 30, 2023 | 7.69% |
| Jun 30, 2023 | 8.33% |
| Mar 31, 2023 | -7.68% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -38.10% |
| Jun 30, 2022 | -19.23% |
| Dec 31, 2019 | -81.25% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Jun 30, 2014 | -28.46% |
| Mar 31, 2013 | -62.81% |
| Dec 31, 2012 | 2.22% |
| Sep 30, 2012 | 0.00% |